Insider · CIK 0001851369
Fredrick M. Ross Jr.
director
Files at CTOS (Custom Truck One Source, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 28, 2025 | CTOS Custom Truck One Source, Inc. | AGrant or award Restricted Stock Unitderivative | +175,000 | $0.00 | $0 | 175,000 | Apr 30, 2025 |
| Apr 1, 2025 | CTOS Custom Truck One Source, Inc. | MOption exercise Common Stock | +175,000 | $0.00 | $0 | 457,575 | Apr 3, 2025 |
| Apr 1, 2025 | CTOS Custom Truck One Source, Inc. | FTax withholding Common Stock | -52,588 | $4.20 | $221k | 404,987 | Apr 3, 2025 |
| Apr 1, 2025 | CTOS Custom Truck One Source, Inc. | MOption exercise Restricted Stock Unitderivative | -87,500 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | CTOS Custom Truck One Source, Inc. | MOption exercise Restricted Stock Unitderivative | -87,500 | $0.00 | $0 | 175,000 | Apr 3, 2025 |
| Dec 31, 2024 | CTOS Custom Truck One Source, Inc. | MOption exercise Common Stock | +31,588 | $0.00 | $0 | 311,101 | Jan 3, 2025 |
| Dec 31, 2024 | CTOS Custom Truck One Source, Inc. | FTax withholding Common Stock | -28,526 | $4.81 | $137k | 282,575 | Jan 3, 2025 |
| Dec 31, 2024 | CTOS Custom Truck One Source, Inc. | MOption exercise Performance Stock Unitderivative | -15,794 | $0.00 | $0 | 122,806 | Jan 3, 2025 |
| Dec 31, 2024 | CTOS Custom Truck One Source, Inc. | MOption exercise Performance Stock Unitderivative | -15,794 | $0.00 | $0 | 122,806 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.